Novel target in the treatment of RPGN: The activated parietal cell

Nephrology Dialysis Transplantation

Volumn 28, Issue 3, 2013, Pages 489-492

  Moeller, Marcus J ^a   Smeets, Bart ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

FSGS; Imatinib; RPGN

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR; IMATINIB; NILOTINIB; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; STEROID;

BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BOWMAN CAPSULE; CELL ACTIVATION; CELL PROLIFERATION; DRUG INDUCED CANCER; DRUG MEGADOSE; FIBROBLAST; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL STROMAL TUMOR; GLOMERULAR PARIETAL EPITHELIAL CELL; GLOMERULONEPHRITIS; HUMAN; IMMUNE DEFICIENCY; INFECTIOUS COMPLICATION; KIDNEY CELL; KIDNEY FIBROSIS; LEUKEMIA; MACROPHAGE; MONOCYTE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BENZAMIDES; FEMALE; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84874867017     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs566     Document Type: Review

References (29)

1. Iyoda M, Shibata T, Wada Y et al. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis. Nephrol Dial Transplant, doi: 10.1093/ndt/gfs414
2. Iyoda M, Shibata T, Kawaguchi M et al. Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis. Kidney Int 2009; 75: 1060-1070
3. Smeets B, Uhlig S, Fuss A et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 2009; 20: 2604-2615
4. Moeller MJ, Soofi A, Hartmann I et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 2004; 15: 61-67.
5. Ding M, Cui S, Li C et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 2006; 12: 1081-1087.
6. Le Hir M, Keller C, Eschmann V et al. Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2001; 12: 2060-2071
7. Le Hir M, Besse-Eschmann V. A novel mechanism of nephron loss in a murine model of crescentic glomerulonephritis. Kidney Int 2003; 63: 591-599.
8. Boucher A, Droz D, Adafer E et al. Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest 1987; 56: 526-533
9. Clarke BE, Ham KN, Tange JD et al. Macrophages and glomerular crescent formation. Studies with rat nephrotoxic nephritis. Pathology 1983; 15: 75-81.
10. Iyoda M, Hudkins KL, Becker-Herman S et al. Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis. J Am Soc Nephrol 2009; 20: 68-77.
11. Cwynarski K, Laylor R, Macchiarulo E et al. Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia 2004; 18: 1332-1339.
12. Dewar AL, Cambareri AC, Zannettino AC et al. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 2005; 105: 3127-3132.
13. Dietz AB, Souan L, Knutson GJ et al. Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood 2004; 104: 1094-1099.
14. Lassila M, Jandeleit-Dahm K, Seah KK et al. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J Am Soc Nephrol 2005; 16: 363-373.
15. Le Meur Y, Tesch GH, Hill PA et al. Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/cfms pathway. J Leukoc Biol 2002; 72: 530-537
16. Paniagua RT, Sharpe O, Ho PP et al. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest 2006; 116: 2633-2642
17. Seggewiss R, Lore K, Greiner E et al. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dosedependent manner. Blood 2005; 105: 2473-2479.
18. Sinai P, Berg RE, Haynie JM et al. Imatinib mesylate inhibits antigen-specific memory CD8 T cell responses in vivo. J Immunol 2007; 178: 2028-2037
19. Zoja C, Corna D, Rottoli D et al. Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease. Kidney Int 2006; 70: 97-103.
20. Ophascharoensuk V, Pippin JW, Gordon KL et al. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 1998; 54: 416-425.
21. Robertson H, Wheeler J, Morley AR. Anti-glomerular basement membrane glomerulonephritis in the mouse: the role of macrophages. Int J Exp Pathol 1995; 76: 157-162
22. Orikasa M, Iwanaga T, Kawachi H et al. Monoclonal antibody against rat podocyte-derived macrophagic cells reacts with crescent- forming cells in an experimental model. Nephrology (Carlton) 2003; 8: 217-223.
23. Waller CF. Imatinib mesylate. Recent Results Cancer Res 2010; 184: 3-20.
24. Wolf D, Tilg H, Rumpold H et al. The kinase inhibitor imatinib - an immunosuppressive drug? Curr Cancer Drug Targets 2007; 7: 251-258
25. van Roeyen CR, Eitner F, Boor P et al. Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet- derived growth factor-D. Kidney Int 2012; 80: 1292-1305.
26. Iyoda M, Shibata T, Hirai Y et al. Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease. J Am Soc Nephrol 2011; 22: 1486-1496.
27. Smeets B, Moeller MJ. Parietal epithelial cells and podocytes in glomerular diseases. Semin Nephrol 2012; 32: 357-367.
28. Smeets B, Kuppe C, Sicking EM et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 2011; 22: 1262-1274.
29. Bollee G, Flamant M, Schordan S et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 2011; 17: 1242-1250.